methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate

Base Information

Chemical Name:methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate
CAS No.:1046480-03-8
Molecular Formula:C₃₁H₄₄O₅Si
Molecular Weight:524.773
Hs Code.:

Synonyms:methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate

Suppliers and Price of methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate

There total 1 articles about methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield: 66.0%

: 26805-54-9,61784-44-9,19530-68-8
dimethyl (Z)-2-(bromomethyl)fumarate

: 172995-43-6
8-bromo-1-(tert-butyldiphenylsilyloxy)-octane

: 1046480-03-8
methyl 11-(tert-butyldiphenylsilyloxy)-2-methylene-3-methoxycarbonylundecanate

Guidance literature:: 8-bromo-1-(tert-butyldiphenylsilyloxy)-octane; With iodine; magnesium; In diethyl ether; at 20 ℃; for 3h;

dimethyl (Z)-2-(bromomethyl)fumarate; In diethyl ether; at -78 ℃; for 19h; Further stages.;
DOI:10.1016/j.tet.2008.05.035